Inventiva (IVA) Amortization (2020 - 2025)
Inventiva (IVA) recorded quarterly Amortization of $150.3 million in Q2 2025, down 22.39% quarter-over-quarter from $193.7 million in Q4 2024, and up 90.17% on a YoY basis from $79.0 million in Q2 2024.
Inventiva (IVA) Amortization (2020 - 2025) Analysis & Trends
Inventiva's Amortization history runs 5 years deep, the most recent figure standing at $150.3 million for Q2 2025.
- In Q2 2025, Amortization rose 90.17% year-over-year to $150.3 million; the TTM figure through Jun 2025 stood at $150.3 million (up 90.17% YoY), while the FY2024 annual figure was $193.7 million, changed N/A from the prior year.
- Amortization was $150.3 million for Q2 2025 at Inventiva, down from $193.7 million in the prior quarter.
- In the past five years, Amortization ranged from a high of $193.7 million in Q4 2024 to a low of $12.2 million in Q1 2021.
- Historically, Amortization has averaged $96.5 million across 4 years, with a median of $79.0 million in 2024.
- The sharpest annual moves came in 2024 and 2025: Amortization soared 67.31% in 2024, then soared 90.17% in 2025.
- A 4-year view of Amortization shows it stood at $12.2 million in 2021, then surged by 288.34% to $47.2 million in 2023, then soared by 309.94% to $193.7 million in 2024, then fell by 22.39% to $150.3 million in 2025.
- The last three Amortization figures came in at $150.3 million (Q2 2025), $193.7 million (Q4 2024), and $79.0 million (Q2 2024), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Amortization (Qtr) |
|---|---|---|---|---|---|
| 1 | Alterity Therapeutics | 788,338.31 Bn | 788,338.28 Bn | - | - |
| 2 | Belite Bio | 56,560.00 Bn | 56,560.00 Bn | - | - |
| 3 | Quantum Biopharma | 17,329.30 Bn | 17,329.30 Bn | - | -13.75 Mn |
| 4 | Legend Biotech | 3,341.00 Bn | 3,340.71 Bn | 242.10 Mn | - |
| 5 | Akari Therapeutics | 1,727.91 Bn | 1,727.91 Bn | - | - |
| 6 | Evaxion A | 1,536.68 Bn | 1,536.67 Bn | - | - |
| 7 | Psyence Biomedical | 238.34 Bn | 238.33 Bn | - | - |
| 8 | Vertex Pharmaceuticals | 113.42 Bn | 106.17 Bn | 2.59 Bn | - |
| 9 | Abivax | 95.45 Bn | 95.45 Bn | - | - |
| 10 | Inventiva | 8.93 Mn | -259.80 Mn | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2025 | 150.32 Mn |
| Jun 30, 2025 | 150.32 Mn |
| Dec 31, 2024 | 193.68 Mn |
| Dec 31, 2024 | 193.68 Mn |
| Jun 30, 2024 | 79.05 Mn |
| Jun 30, 2024 | 79.05 Mn |
| Jun 30, 2023 | 47.25 Mn |
| Jun 30, 2023 | 47.25 Mn |
| Mar 31, 2021 | 12.17 Mn |
| Mar 31, 2021 | 12.17 Mn |
| Jun 30, 2020 | 57.99 Mn |
| Jun 30, 2020 | 57.99 Mn |